Risk factors for intestinal metaplasia in a southeastern Chinese population: an analysis of 28,745 cases
- PMID: 27832356
- PMCID: PMC11819401
- DOI: 10.1007/s00432-016-2299-9
Risk factors for intestinal metaplasia in a southeastern Chinese population: an analysis of 28,745 cases
Abstract
Purpose: To identify risk factors for intestinal metaplasia in a southeastern Chinese population.
Methods: Subjects who underwent upper GI endoscopy and endoscopic biopsy in the First Affiliated Hospital of Nanjing Medical University from 2008 to 2013 were included into this study. Various demographic, geographic, clinical and pathological data were analyzed separately to identify risk factors for intestinal metaplasia.
Results: The incidence of intestinal metaplasia differed significantly in 17 municipal areas ranging from 16.79 to 38.56% and was positively correlated with the age range of 40-70 years, male gender, gastric ulcer, bile reflux, Helicobacter pylori infection, atrophic gastritis, dysplasia, gastric cancer, degree of chronic and acute inflammation, and gross domestic product per capita (P < 0.01). Multivariate linear regression analysis indicated that only gross domestic product per capita revealed a significant difference in the incidence of intestinal metaplasia among all factors mentioned.
Conclusion: This study confirms age, male gender, gastric ulcer, bile reflux, H. pylori infection, severe degree of chronic and acute inflammation to be the risk factors for intestinal metaplasia. We speculate that the gross domestic product per capita of different areas may be a potential independent risk factor impacting the incidence of intestinal metaplasia.
Keywords: Gross domestic product per capita; Helicobacter pylori infection; Inflammation; Intestinal metaplasia; Risk factors.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Unveiling Cancer-Related Metaplastic Cells in Both Helicobacter pylori Infection and Autoimmune Gastritis.Gastroenterology. 2025 Jan;168(1):53-67. doi: 10.1053/j.gastro.2024.08.032. Epub 2024 Sep 3. Gastroenterology. 2025. PMID: 39236896
-
Association of PRMT6 genetic polymorphism with Helicobacter pylori-induced gastric mucosal atrophy was found using a data-driven approach with gene expression database.Microb Pathog. 2025 Sep;206:107809. doi: 10.1016/j.micpath.2025.107809. Epub 2025 Jun 14. Microb Pathog. 2025. PMID: 40523565
-
Prevalence of Gastric Precursor Lesions in Countries With Differential Gastric Cancer Burden: A Systematic Review and Meta-analysis.Clin Gastroenterol Hepatol. 2024 Aug;22(8):1605-1617.e46. doi: 10.1016/j.cgh.2024.02.023. Epub 2024 Mar 2. Clin Gastroenterol Hepatol. 2024. PMID: 38438000 Free PMC article.
-
Epidemiology of Helicobacter pylori, gastric precancerous lesions and gastric cancer: a multicenter, population-based cross-sectional study in Nanjing.BMC Infect Dis. 2025 May 27;25(1):766. doi: 10.1186/s12879-025-11147-3. BMC Infect Dis. 2025. PMID: 40426075 Free PMC article.
-
Systematic review of the prevalence of gastric intestinal metaplasia and its area-level association with smoking.Gac Sanit. 2008 May-Jun;22(3):236-47; discussion 246-7. doi: 10.1157/13123970. Gac Sanit. 2008. PMID: 18579050
Cited by
-
GATA4 Forms a Positive Feedback Loop with CDX2 to Transactivate MUC2 in Bile Acids-Induced Gastric Intestinal Metaplasia.Gut Liver. 2024 May 15;18(3):414-425. doi: 10.5009/gnl220394. Epub 2023 Mar 2. Gut Liver. 2024. PMID: 36860162 Free PMC article.
-
MicroRNA-92a-1-5p increases CDX2 by targeting FOXD1 in bile acids-induced gastric intestinal metaplasia.Gut. 2019 Oct;68(10):1751-1763. doi: 10.1136/gutjnl-2017-315318. Epub 2019 Jan 11. Gut. 2019. PMID: 30635407 Free PMC article.
-
Bile acids promote gastric intestinal metaplasia by upregulating CDX2 and MUC2 expression via the FXR/NF-κB signalling pathway.Int J Oncol. 2019 Mar;54(3):879-892. doi: 10.3892/ijo.2019.4692. Epub 2019 Jan 22. Int J Oncol. 2019. PMID: 30747230 Free PMC article.
-
Endoscopy for Gastric Cancer Screening Is Cost Effective for Asian Americans in the United States.Clin Gastroenterol Hepatol. 2020 Dec;18(13):3026-3039. doi: 10.1016/j.cgh.2020.07.031. Epub 2020 Jul 21. Clin Gastroenterol Hepatol. 2020. PMID: 32707341 Free PMC article. Review.
-
Weiwei Decoction alleviates gastric intestinal metaplasia through the olfactomedin 4/nucleotide-binding oligomerization domain 1/caudal-type homeobox gene 2 signaling pathway.World J Gastrointest Oncol. 2024 Jul 15;16(7):3211-3229. doi: 10.4251/wjgo.v16.i7.3211. World J Gastrointest Oncol. 2024. PMID: 39072182 Free PMC article.
References
-
- Chacaltana Mendoza A, Soriano Alvarez C, Frisancho Velarde O (2012) Associated risk factors in patients with gastric intestinal metaplasia with mild gastroduodenal disease. Is it always related to Helicobacter pylori infection? Rev Gastroenterol Peru 32:50–57 - PubMed
-
- Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M (1975) A model for gastric cancer epidemiology. Lancet 2:58–60 - PubMed
-
- Czekaj R, Majka J, Ptak-Belowska A, Szlachcic A, Targosz A, Magierowska K, Strzalka M, Magierowski M, Brzozowski T (2016) Role of curcumin in protection of gastric mucosa against stress-induced gastric mucosal damage. Involvement of hypoacidity, vasoactive mediators and sensory neuropeptides. J Physiol Pharmacol 67:261–275 - PubMed
-
- de Vries AC, van Grieken NC, Looman CW, Casparie MK, de Vries E, Meijer GA, Kuipers EJ (2008) Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 134:945–952. doi:10.1053/j.gastro.2008.01.071 - PubMed
-
- den Hoed CM, van Eijck BC, Capelle LG, van Dekken H, Biermann K, Siersema PD, Kuipers EJ (2011) The prevalence of premalignant gastric lesions in asymptomatic patients: predicting the future incidence of gastric cancer. Eur J Cancer 47:1211–1218. doi:10.1016/j.ejca.2010.12.012 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical